Compare HLT & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLT | COR |
|---|---|---|
| Founded | 1919 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.7B | 68.5B |
| IPO Year | 2013 | 2001 |
| Metric | HLT | COR |
|---|---|---|
| Price | $295.77 | $351.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $308.27 | ★ $395.23 |
| AVG Volume (30 Days) | ★ 1.9M | 934.6K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | 0.20% | ★ 0.68% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | ★ 6.12 | 2.87 |
| Revenue | $12,039,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $9.59 | $8.97 |
| Revenue Next Year | $8.38 | $6.76 |
| P/E Ratio | ★ $48.82 | $122.90 |
| Revenue Growth | 7.74 | ★ 9.31 |
| 52 Week Low | $196.04 | $252.49 |
| 52 Week High | $333.86 | $377.54 |
| Indicator | HLT | COR |
|---|---|---|
| Relative Strength Index (RSI) | 39.14 | 42.65 |
| Support Level | $286.40 | $331.73 |
| Resistance Level | $306.28 | $353.18 |
| Average True Range (ATR) | 7.83 | 7.16 |
| MACD | -2.45 | -2.18 |
| Stochastic Oscillator | 16.59 | 6.37 |
Hilton Worldwide Holdings operates 1.3 million rooms across its 25 brands, serving the premium economy through luxury segments. Hampton and Hilton are the two largest brands, representing 27% and 18%, respectively, of the company's total rooms, as of Dec. 31, 2024. Recent brands launched over the past few years include Home2, Curio, Canopy, Spark, Tru, Tempo, LivSmart, and Outset. Additionally, there is a partnership with Small Luxury Hotels of the World and acquisitions of NoMad and Graduate Hotels. Managed and franchised hotels represent the vast majority of adjusted EBITDA, predominantly from the Americas.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.